Karakaş, Z. 2022. An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results. AMERICAN JOURNAL OF HEMATOLOGY , 1234-12243.

Karakaş, Z., (2022). An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results. AMERICAN JOURNAL OF HEMATOLOGY , 1234-12243.

Karakaş, Zeynep. "An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results," AMERICAN JOURNAL OF HEMATOLOGY , 1234-12243, 2022

Karakaş, Zeynep. "An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results." AMERICAN JOURNAL OF HEMATOLOGY , pp.1234-12243, 2022

Karakaş, Z. (2022) . "An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results." AMERICAN JOURNAL OF HEMATOLOGY , pp.1234-12243.

@article{article, author={Zeynep KARAKAŞ}, title={An open-label, multicenter, efficacy and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2022, pages={1234-12243} }